Giovanna Scarfone
Overview
Explore the profile of Giovanna Scarfone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuhn E, Gambini D, Runza L, Ferrero S, Scarfone G, Bulfamante G, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001520
Endometrial carcinoma (EC) is the most frequent gynecological cancer, with an increasing incidence and mortality in recent times. The last decade has represented a true revolution with the development of...
2.
Girardelli S, Bonomo B, Papale M, Di Loreto E, Grossi E, Scarfone G, et al.
Clin Breast Cancer
. 2024 Jan;
24(3):199-203.
PMID: 38212190
Background: Pregnancy associated breast cancer is the most common cancer diagnosed during pregnancy. When chemotherapy is indicated, although it is more common to use anthracycline-based chemotherapy as a first treatment,...
3.
Vasta F, Cormio G, Cassani C, Bergamini A, Scarfone G, Ferrandina G, et al.
Gynecol Oncol
. 2023 Dec;
181:28-32.
PMID: 38104526
Background: Malignant ovarian germ cell tumors usually occur in young women. The standard of care is fertility sparing surgery and comprehensive surgical staging followed by adjuvant chemotherapy with BEP (bleomycin,...
4.
Ferrigno Guajardo A, Vaca-Cartagena B, Mayer E, Bousrih C, Oluchi O, Saura C, et al.
J Natl Cancer Inst
. 2023 Dec;
116(2):239-248.
PMID: 38059798
Introduction: The addition of taxanes to anthracycline-based chemotherapy is considered standard of care in the treatment of breast cancer. However, there are insufficient data regarding the safety of taxanes during...
5.
Esposito G, Franchi M, Santucci C, Scarfone G, Parazzini F, La Vecchia C, et al.
BMC Womens Health
. 2023 Nov;
23(1):586.
PMID: 37940884
Background: A diagnosis of cancer during pregnancy or within one year after the end of pregnancy is a major clinical and public health issue. The current study aimed at estimating...
6.
Pierannunzio D, Maraschini A, Lopez T, Donati S, Amodio R, Bianconi F, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686581
The aim of this study is to describe the frequency and trend of pregnancy-associated cancer (PAC) in Italy, an increasingly relevant phenomenon due to postponing age at childbirth. To this...
7.
Sajjadi E, Venetis K, Ivanova M, Noale M, Blundo C, Di Loreto E, et al.
Front Oncol
. 2023 Sep;
13:1116569.
PMID: 37671051
Background: Breast cancer during pregnancy (PrBC) is a rare condition known for its aggressive clinical behavior. The presence of tumor-infiltrating lymphocytes (TILs) has been shown to have a significant impact...
8.
Sajjadi E, Venetis K, Noale M, Azim Jr H, Blundo C, Bonizzi G, et al.
Cells
. 2022 Jul;
11(15).
PMID: 35892583
Breast cancer during pregnancy (PrBC) is a rare tumor with only a little information on its immune landscape. Here, we sought to characterize the cellular composition of the tumor microenvironment...
9.
Bogani G, Scambia G, Cimmino C, Fanfani F, Costantini B, Loverro M, et al.
J Gynecol Oncol
. 2021 Dec;
33(1):e10.
PMID: 34910391
Objective: Coronavirus disease 2019 (COVID-19) outbreak has correlated with the disruption of screening activities and diagnostic assessments. Endometrial cancer (EC) is one of the most common gynecological malignancies and it...
10.
Blundo C, Giroda M, Fusco N, Sajjadi E, Venetis K, Leonardi M, et al.
Front Oncol
. 2021 Sep;
11:723693.
PMID: 34504801
Breast cancer is the most common malignancy occurring during gestation. In early-stage breast cancer during pregnancy (PrBC), breast-conserving surgery (BCS) with delayed RT is a rational alternative to mastectomy, for...